Why is Lyka Labs falling/rising?

As of 17-Sep, Lyka Labs Ltd is currently priced at 100.00, with no change in price (0.00%). The stock has shown a slight decline of 0.07% over the past week, while it has increased by 0.15% over the past month. However, it has significantly underperformed in the longer term, with a year-to-date decline of 36.97% and a 36.08% drop over the past year. Today's price summary indicates that the stock's performance is in line with its sector, but it is trading below its 50-day, 100-day, and 200-day moving averages, despite being above its 5-day and 20-day averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 66.95% against the 5-day average. While the company has demonstrated high management efficiency and healthy long-term growth, it also carries a high debt-to-equity ratio of 2.75, which raises concerns about its financial stability.
In the broader market context, the Sensex has increased by 1.56% over the past week and 2.60% over the past month, indicating a positive trend in the market that Lyka Labs is not following. The stock's underperformance is evident as it has generated negative returns compared to the benchmark indices over various periods, including a significant decline over the past three years. Despite the company's positive financial results in recent quarters and a fair valuation compared to peers, the high debt levels and overall below-par performance in both the near and long term suggest that investor confidence may be waning, contributing to the stock's struggles in a rising market.